Wednesday, July 8, 2026

biotech · Moderately to Severely Active Ulcerative Colitis · Inflammatory Bowel Diseases · ODTX

Odyssey Therapeutics

News and analysis for Odyssey Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

San Ramon, USA HQ
3 Employees
Public company Type
ODTX · NYSE Ticker
Company details
Status
Public
HQ
San Ramon, USA
Employees
3
Programs
4
Drugs
6
Patents
1
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Odyssey Therapeutics — regulatory, clinical, and market coverage.

News and analysis for Odyssey Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Odyssey Therapeutics yet.

Back to company overview →